Ticagrelor has been evaluated across numerous clinical trials spanning early- to late-stage phases, investigating a broad spectrum of cardiovascular and cerebrovascular conditions including acute coronary syndrome, myocardial infarction, ischaemic stroke, transient ischaemic attack, coronary artery disease, and thrombosis. Sponsored by industry leaders such as AstraZeneca as well as academic institutions like University Hospital Heidelberg and the University of Florida, these studies encompass recruitment statuses ranging from active recruitment to completed phases. Landmark late-stage evaluations have focused on key clinical outcomes such as vascular event prevention and post-stroke management.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07257198 | RECRUITING | NSTEMI - Non-ST Segment Elevation MI; STEMI (ST Elevation MI); Myocardial Infarction |
Montreal Heart Institute |
2026-03-03 | PHASE3 |
| NCT07507500 | NOT_YET_RECRUITING | Myocardial Infarction (MI) |
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz |
2026-07 | PHASE4 |
| NCT06451198 | RECRUITING | Coronary Artery Disease; Antiplatelet Drugs |
Shanghai Zhongshan Hospital |
2025-05-19 | PHASE4 |
| NCT07582835 | RECRUITING | Coronary Artery Disease; Percutaneous Coronary Intervention; Acute Coronary Syndromes; Antiplatelet Therapy; Single Antiplatelet Therapy; Coagulation Factors |
Cardiocentro Ticino |
2026-04-20 | PHASE3 |
| NCT05476991 | RECRUITING | Stroke; Stroke, Ischemic; Atherosclerosis; Myocardial Infarction; Coronary Syndrome; TIA; Cardiac Disease; Cerebral Infarction |
Assistance Publique - Hôpitaux de Paris |
2023-05-17 | PHASE3 |
| NCT06714526 | RECRUITING | Intracranial Atherosclerosis |
Sunnybrook Health Sciences Centre |
2025-10-07 | |
| NCT06853535 | RECRUITING | Acute Ischemic Stroke; Clopidogrel Resistance |
Sichuan Provincial People's Hospital |
2025-05-23 | PHASE3 |
| NCT05283356 | RECRUITING | Severe Aortic Valve Stenosis; Aortic Valve Stenosis; Transcatheter Aortic Valve Replacement (TAVR); Transcatheter Aortic Valve Implantation (TAVI) |
Fundacin Biomedica Galicia Sur |
2022-01-21 | PHASE4 |
| NCT07613840 | RECRUITING | Peripheral Arterial Disease (PAD); Amputation; Thrombosis; Thrombosis (Stent Thrombosis); Platelet Aggregation Inhibitors; Thromboelastography (TEG); PRU(Platelet Reactivity Unit) |
Massachusetts General Hospital |
2025-04-29 | |
| NCT07438886 | NOT_YET_RECRUITING | Healthy Volunteer |
Advenchen Laboratories Nanjing Ltd. |
2026-03-02 | PHASE1 |
| NCT06981390 | NOT_YET_RECRUITING | Coronary Artery Disease; Coronary Artery Bypass Grafting; Saphenous Vein; Dual Antiplatelet Therapy |
Kexiang Liu, MD |
2026-05-01 | |
| NCT05047172 | ACTIVE_NOT_RECRUITING | Intracranial Arteriosclerosis; Stroke |
University of Florida |
2022-08-02 | PHASE3 |
| NCT04755387 | RECRUITING | Acute Myocardial Infarction |
Dong-A University |
2023-03-27 | PHASE4 |
| NCT05997693 | RECRUITING | Chronic Coronary Disease |
Weill Medical College of Cornell University |
2024-08-15 | PHASE3 |
| NCT06228456 | RECRUITING | Coronary Artery Disease |
University of Florida |
2024-04-01 | PHASE4 |
| NCT04937699 | RECRUITING | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2023-03-28 | PHASE4 |
| NCT07203846 | NOT_YET_RECRUITING | ACS - Acute Coronary Syndrome; Ticagrelor; Microbiota; Platelet Aggregation; Myocardial Infarction (MI); Blood Platelets; Drug Effects; Platelet Aggregation Inhibitors; Drug Resistance; Platelet Function Tests; Dysbiosis; Anti-Bacterial Agents; Rifaximin |
Collegium Medicum w Bydgoszczy |
2026-01-01 | PHASE4 |
| NCT05681702 | RECRUITING | Coronary Artery Disease |
University of Florida |
2023-02-15 | PHASE4 |
| NCT07080684 | NOT_YET_RECRUITING | Chronic Coronary Syndrome |
University of Messina |
2025-12-01 | PHASE4 |
| NCT06756945 | NOT_YET_RECRUITING | ST-elevation Myocardial Infarction (STEMI) |
Beijing Anzhen Hospital |
2025-01 | PHASE4 |
| NCT06691191 | RECRUITING | Coronary Artery Disease |
University of Florida |
2025-01-08 | PHASE4 |
| NCT06588595 | RECRUITING | Coronary Arterial Disease (CAD) |
University of Florida |
2024-11-01 | PHASE4 |
| NCT06400940 | RECRUITING | Intracranial Aneurysm |
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health |
2023-08-17 | PHASE4 |
| NCT06486363 | NOT_YET_RECRUITING | Intracranial Aneurysms; Antiplatelet Drugs |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2024-08-01 | PHASE4 |
| NCT04695106 | RECRUITING | Atrial Fibrillation; Antithrombotic Therapy; Acute Coronary Syndrome; Percutaneous Coronary Interventions |
Medical University of Gdansk |
2021-10-25 | PHASE4 |
| NCT06653348 | RECRUITING | Ischemic Stroke; Transient Ischemic Attack |
Mazandaran University of Medical Sciences |
2024-04-01 | PHASE2; PHASE3 |
| NCT04989257 | UNKNOWN | High Ischemic Risk |
Yonsei University |
2021-08 | |
| NCT04981041 | COMPLETED | Acute Coronary Syndrome; Atrial Fibrillation |
Ludwig-Maximilians - University of Munich |
2021-12-16 | PHASE4 |
| NCT07597239 | ACTIVE_NOT_RECRUITING | Thrombosis; Arterial Occlusive Diseases; Thromboelastography (TEG); Peripheral Arterial Disease(PAD); Stent Thrombosis; Platelet Inhibition; PRU(Platelet Reactivity Unit) |
Massachusetts General Hospital |
2020-11-01 | |
| NCT07268859 | RECRUITING | Acute Coronary Syndromes; Ticagrelor; Dyspnea |
Acibadem University |
2025-03-15 | |
| NCT05986968 | ACTIVE_NOT_RECRUITING | ST Elevation Myocardial Infarction |
Radboud University Medical Center |
2023-07-06 | |
| NCT06316570 | COMPLETED | Ischemic Stroke, Acute |
Beijing Tiantan Hospital |
2024-04-03 | PHASE3 |
| NCT06301776 | UNKNOWN | Brain Disease; Vertebral Artery Stenosis |
The Fourth Affiliated Hospital of China Medical University |
2023-12-05 | |
| NCT06613191 | NOT_YET_RECRUITING | Coronary Arterial Disease (CAD); Peripheral Vascular Disease |
Ochsner Health System |
2024-10-01 | PHASE4 |
| NCT06509893 | RECRUITING | Coronary Artery Disease |
Shiraz University of Medical Sciences |
2024-08-01 | PHASE4 |
| NCT04240834 | RECRUITING | Acute Coronary Syndrome; Interventional Cardiology |
Fu Wai Hospital, Beijing, China |
2021-02-01 | PHASE4 |
| NCT06561867 | UNKNOWN | Ischemic Stroke |
Kafrelsheikh University |
2024-08-30 | PHASE3 |
| NCT06591377 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2024-08-10 | PHASE3 |
| NCT06591338 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2024-09-01 | PHASE3 |
| NCT05885932 | RECRUITING | Ischemic Stroke; Vertebral Artery Stenosis |
Xuanwu Hospital, Beijing |
2023-08-25 | |
| NCT05183178 | COMPLETED | Acute Coronary Syndrome |
Vastra Gotaland Region |
2022-02-01 | PHASE4 |
| NCT05380063 | COMPLETED | Coronary Artery Disease; Coronary Artery Bypass Grafting; Dual Antiplatelet Therapy; Bleeding; Myocardial Infarction; Myocardial Ischemia; Angina Pectoris |
China National Center for Cardiovascular Diseases |
2023-02-14 | PHASE4 |
| NCT06015477 | UNKNOWN | Intracranial Aneurysm; Stent Complication |
The First Affiliated Hospital with Nanjing Medical University |
2024-01-01 | |
| NCT05149560 | COMPLETED | Acute Myocardial Infarction |
Vastra Gotaland Region |
2021-12-14 | PHASE2 |
| NCT06202755 | UNKNOWN | Ischemic Stroke |
Kafrelsheikh University |
2024-03-30 | PHASE3 |
| NCT05767723 | ACTIVE_NOT_RECRUITING | Acute Coronary Syndrome |
Hospital Israelita Albert Einstein |
2023-02-06 | PHASE4 |
| NCT03797651 | UNKNOWN | Coronary Artery Disease, Acute Coronary Syndrome |
Yonsei University |
2019-04-24 | |
| NCT03560310 | ACTIVE_NOT_RECRUITING | Acute Coronary Syndrome |
Vastra Gotaland Region |
2018-06-29 | PHASE4 |
| NCT06318481 | COMPLETED | Stent Thrombosis; Myocardial Infarction, Acute |
National Institute of Cardiovascular Diseases, Pakistan |
2024-02-19 | PHASE3 |
| NCT03476369 | TERMINATED | Percutaneous Coronary Intervention |
The Guthrie Clinic |
2018-04-18 | PHASE4 |
| NCT07444164 | COMPLETED | Healthy |
Laboratorios Silanes S.A. de C.V. |
2025-01-13 | PHASE1 |
| NCT04483583 | COMPLETED | Coronary Artery Disease |
University of Florida |
2020-12-08 | PHASE4 |
| NCT04255602 | UNKNOWN | Acute Coronary Syndrome; Coronary Stent Implantation |
Shanghai Tong Ren Hospital |
2020-02-19 | PHASE4 |
| NCT07622056 | COMPLETED | Chronic Coronary Syndrome; Coronary Artery Disease; Percutaneous Coronary Intervention |
Kaohsiung Veterans General Hospital. |
2024-01-03 | PHASE4 |
| NCT05779059 | UNKNOWN | Non ST Segment Elevation Acute Coronary Syndrome; Non-ST-Segment Elevation Myocardial Infarction (NSTEMI); Unstable Angina |
Collegium Medicum w Bydgoszczy |
2023-04-01 | PHASE3 |
| NCT06196047 | UNKNOWN | Ischemic Stroke |
Kafrelsheikh University |
2023-12-01 | PHASE3 |
| NCT06584812 | COMPLETED | Acute Coronary Syndrome; Ischemic Stroke |
Tianjin Institute of Pharmaceutical Research Co., Ltd |
2024-09-09 | PHASE1 |
| NCT06088433 | UNKNOWN | Coronary Heart Disease |
Fu Wai Hospital, Beijing, China |
2023-11-15 | PHASE4 |
| NCT06554821 | COMPLETED | Healthy Participants |
AstraZeneca |
2024-08-05 | PHASE1 |
| NCT06591390 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2022-02-09 | PHASE3 |
| NCT06671470 | COMPLETED | Insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
2024-08-22 | PHASE1 |
| NCT06591312 | RECRUITING | Ischemic Stroke |
Kafrelsheikh University |
2022-05-01 | PHASE3 |
| NCT04286438 | COMPLETED | Hemorrhage; Urgent Surgery; Invasive Procedure |
SFJ Pharmaceuticals, Inc. |
2020-07-15 | PHASE3 |
| NCT06233266 | UNKNOWN | Healthy Subjects |
Bio-innova Co., Ltd |
2024-06-18 | PHASE1 |
| NCT04718025 | UNKNOWN | STEMI; NSTEMI; Unstable Angina |
Collegium Medicum w Bydgoszczy |
2022-02-07 | PHASE3 |
| NCT04307485 | UNKNOWN | Senior Acute Coronary Syndrome Patients After PCI |
Shanghai Tong Ren Hospital |
2020-03-10 | PHASE4 |
| NCT04307511 | UNKNOWN | Acute Coronary Syndrome Patients With Diabetes After PCI |
Shanghai Tong Ren Hospital |
2020-04-20 | PHASE4 |
| NCT03729401 | TERMINATED | Coronary Artery Disease; Myocardial Infarction |
Ottawa Heart Institute Research Corporation |
2019-08-22 | PHASE4 |
| NCT05831462 | UNKNOWN | Ticagrelor |
Assiut University |
2023-06-01 | PHASE1; PHASE2 |
| NCT06667349 | COMPLETED | STEMI - ST Elevation Myocardial Infarction; Stent Thrombosis; Antiplatelet Agents |
National Institute of Cardiovascular Diseases, Pakistan |
2023-08-24 | PHASE4 |
| NCT04971356 | ACTIVE_NOT_RECRUITING | Antiplatelet Drug; Acute Coronary Syndrome; Angioplasty, Balloon |
Xijing Hospital |
2021-11-01 | |
| NCT03551964 | COMPLETED | Acute Myocardial Infarction; Cardiogenic Shock |
Faculty Hospital Kralovske Vinohrady |
2018-08-01 | PHASE4 |
| NCT05209412 | UNKNOWN | De Novo Stenosis; Coronary Artery Disease; Percutaneous Coronary Intervention |
Xijing Hospital |
2022-02-01 | |
| NCT04442919 | COMPLETED | Unstable Angina |
Collegium Medicum w Bydgoszczy |
2020-06-01 | PHASE4 |
| NCT04484259 | COMPLETED | Diabetes Mellitus, Type 2; Coronary Artery Disease |
University of Florida |
2021-03-31 | PHASE4 |
| NCT05166538 | UNKNOWN | Multi Vessel Coronary Artery Disease |
Yonsei University |
2022-02-01 | PHASE4 |
| NCT05116995 | UNKNOWN | Thrombosis; Myocardial Infarction |
Nova Scotia Health Authority |
2021-11-01 | PHASE4 |
| NCT04738097 | COMPLETED | Ischemic Stroke; Transient Ischemic Attack |
Mazandaran University of Medical Sciences |
2021-08-08 | PHASE3 |
| NCT05553613 | COMPLETED | Ischemic Stroke |
Kafrelsheikh University |
2022-10-01 | PHASE3 |
| NCT06120725 | COMPLETED | Ischemic Stroke |
Kafrelsheikh University |
2021-09-01 | PHASE3 |
| NCT04976530 | COMPLETED | Hemorrhage, Surgical; Blood Loss, Surgical; Blood Loss, Postoperative; Hemorrhage Postoperative |
CytoSorbents, Inc |
2021-08-31 | |
| NCT03331484 | COMPLETED | Atrial Fibrillation; Acute Coronary Syndrome |
Ottawa Heart Institute Research Corporation |
2018-11-01 | PHASE3 |
| NCT02494895 | UNKNOWN | Acute Coronary Syndrome |
Yonsei University |
2015-08-01 | PHASE4 |
| NCT04927949 | COMPLETED | ST-elevation Myocardial Infarction |
University Hospital, Caen |
2021-06-08 | PHASE4 |
| NCT04007055 | TERMINATED | Peripheral Artery Disease; Clopidogrel, Poor Metabolism of; Peripheral Vascular Disease; Artery Disease; Peripheral Arterial Occlusive Disease |
Marissa Jarosinski |
2019-08-09 | PHASE3 |
| NCT05858918 | COMPLETED | Stable Chronic Angina |
Shiraz University of Medical Sciences |
2022-10-01 | |
| NCT05774431 | Recruiting | Acute Myocardial Infarction |
University Hospital Heidelberg|AstraZeneca |
2023-03-13 | -- |
| NCT03357874 | COMPLETED | Acute Coronary Syndrome |
Assistance Publique Hopitaux De Marseille |
2018-10-28 | PHASE3 |
| NCT05373277 | UNKNOWN | Pharmacokinetics |
Helsinki University Central Hospital |
2022-05-11 | PHASE1 |
| NCT05210595 | UNKNOWN | Acute Myocardial Infarction; Ticagrelor |
Dong-A University |
2022-01-01 | PHASE4 |
| NCT04688723 | UNKNOWN | Coronary Artery Disease; Myocardial Ischemia; Myocardial Infarction; Atrial Fibrillation |
Zuyderland Medisch Centrum |
2020-12-23 | PHASE4 |
| NCT04946929 | UNKNOWN | Hepatic Artery Thrombosis; Liver Transplant; Complications; Pediatric Disease |
RenJi Hospital |
2021-07-31 | PHASE3 |
| NCT05162131 | TERMINATED | Healthy |
SFJ Pharmaceuticals, Inc. |
2021-12-25 | PHASE1 |
| NCT03161678 | COMPLETED | Myocardial Infarction; Thrombosis; Platelet Dysfunction |
University of Maryland, Baltimore |
2017-08-22 | PHASE4 |
| NCT04091074 | UNKNOWN | Carotid Stenosis |
Assiut University |
2022-01-01 | PHASE1 |
| NCT04744571 | UNKNOWN | Coronary Artery Disease; Coronary Occlusion; Percutaneous Coronary Intervention; Chronic Total Occlusion of Coronary Artery; Drug-Eluting Stents |
Beijing Anzhen Hospital |
2021-02 | |
| NCT05093790 | COMPLETED | Coronary Artery Disease; Healthy Participants |
Bristol-Myers Squibb |
2022-03-25 | PHASE2 |
| NCT04293172 | WITHDRAWN | Sickle Cell Disease |
AstraZeneca |
2020-06-30 | PHASE3 |
| NCT04766437 | COMPLETED | Non ST Segment Elevation Acute Coronary Syndrome |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2021-02-19 | PHASE2 |
| NCT05516784 | COMPLETED | Coronary Artery Disease (CAD) |
Universiti Sains Malaysia |
2019-09-01 | PHASE4 |
| NCT04739384 | COMPLETED | Acute Coronary Syndrome; STEMI; NSTEMI; Coronary Artery Disease; Myocardial Infarction |
Federico II University |
2021-04-01 | PHASE3 |
| NCT02677545 | COMPLETED | Carotid Artery Stenosis |
University Hospital, Basel, Switzerland |
2016-12 | PHASE2 |
| NCT04057300 | COMPLETED | Acute Coronary Syndrome |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2018-10-01 | PHASE4 |
| NCT04006288 | COMPLETED | Coronary Artery Disease |
University of Florida |
2019-09-06 | PHASE4 |
| NCT04588727 | COMPLETED | Cardiovascular Disease |
AstraZeneca |
2020-10-15 | PHASE1 |
| NCT05283356 | Recruiting | Severe Aortic Valve Stenosis|Aortic Valve Stenosis|Transcatheter Aortic Valve Replacement (TAVR)|Transcatheter Aortic Valve Implantation (TAVI) |
Fundacin Biomedica Galicia Sur |
2022-01-21 | Phase 4 |
| NCT03869268 | COMPLETED | Acute Coronary Syndrome |
Sheffield Teaching Hospitals NHS Foundation Trust |
2019-04-24 | PHASE4 |
| NCT03775746 | UNKNOWN | Acute Coronary Syndrome |
East and North Hertfordshire NHS Trust |
2019-01-08 | PHASE4 |
| NCT05474053 | COMPLETED | Cardiovascular Diseases; Acute Coronary Syndrome |
Cairo University |
2021-11-13 | PHASE3 |
| NCT04945616 | COMPLETED | Thrombosis |
Jiangsu HengRui Medicine Co., Ltd. |
2021-07-13 | PHASE1 |
| NCT04069234 | WITHDRAWN | Diabetes Mellitus; Microvascular Coronary Artery Disease |
Region Skane |
2019-09-15 | PHASE3 |
| NCT04625764 | TERMINATED | Acute Coronary Syndrome |
CytoSorbents Europe GmbH |
2021-02-23 | |
| NCT03649711 | COMPLETED | Chronic Kidney Diseases; Heart Attack; Stroke, Ischemic |
University of Arkansas |
2018-11-01 | PHASE3 |
| NCT04122170 | COMPLETED | Healthy |
SFJ Pharmaceuticals, Inc. |
2019-09-24 | PHASE2 |
| NCT04570345 | UNKNOWN | ST Elevation Myocardial Infarction |
Dong-A University |
2021-01-01 | PHASE4 |
| NCT04634162 | COMPLETED | Coronary Artery Disease |
University of Florida |
2021-02-09 | PHASE4 |
| NCT04567290 | UNKNOWN | Acute Coronary Syndrome |
Centro Hospitalario La Concepcion |
2020-10-07 | PHASE4 |
| NCT03789916 | RECRUITING | Coronary Artery Disease |
Campus Bio-Medico University |
2019-01-02 | PHASE3 |
| NCT04078737 | COMPLETED | Stroke; Transient Ischemic Attack |
Beijing Tiantan Hospital |
2019-09-23 | PHASE3 |
| NCT04734353 | UNKNOWN | Coronary Artery Disease |
Gyeongsang National University Hospital |
2020-01-15 | PHASE4 |
| NCT03078465 | WITHDRAWN | Coronary Artery Disease |
Nanjing First Hospital, Nanjing Medical University |
2017-06-20 | PHASE3 |
| NCT04116931 | UNKNOWN | Acute Coronary Syndrome (ACS) |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-22 | PHASE4 |
| NCT04131959 | TERMINATED | Emergent Cardiothoracic Surgery; Bleeding; Drug Removal |
CytoSorbents, Inc |
2019-10-29 | |
| NCT03273075 | UNKNOWN | Cardiopulmonary Arrest With Successful Resuscitation; ACS - Acute Coronary Syndrome; Hypothermia, Induced |
Medical University of Vienna |
2017-09 | PHASE4 |
| NCT02668562 | COMPLETED | Acute Coronary Syndrome |
Ottawa Heart Institute Research Corporation |
2016-02 | |
| NCT04338919 | UNKNOWN | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
Fujian Medical University |
2020-04-14 | |
| NCT04331145 | COMPLETED | Symptomatic Aortic Stenosis |
Andres Iñiguez Romo |
2020-06-23 | PHASE4 |
| NCT05247385 | COMPLETED | Coronary Artery Disease |
University of Sao Paulo |
2017-03-20 | PHASE4 |
| NCT02018055 | COMPLETED | Acute Myocardial Infarction |
The Catholic University of Korea |
2014-02-14 | PHASE4 |
| NCT03620760 | UNKNOWN | Unstable Angina Pectoris; Coronary Stent Implantation |
Xiaofan Wu |
2018-08-07 | PHASE4 |
| NCT03708588 | COMPLETED | Percutaneous Coronary Intervention |
Wake Forest University Health Sciences |
2018-09-19 | PHASE4 |
| NCT04060914 | UNKNOWN | Antiplatelet Therapy; Coronary Artery Disease; Percutaneous Coronary Intervention |
Beijing Anzhen Hospital |
2019-08-30 | PHASE4 |
| NCT04001894 | COMPLETED | Platelet Reactivity |
First Affiliated Hospital of Harbin Medical University |
2019-07-02 | PHASE4 |
| NCT02302508 | WITHDRAWN | Diabetes |
Centre hospitalier de l'Université de Montréal (CHUM) |
2019-09-01 | PHASE4 |
| NCT02701140 | COMPLETED | Myocardial Ischemia |
Italo Porto |
2016-06 | PHASE2; PHASE3 |
| NCT01742117 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome; Stenosis |
Mayo Clinic |
2013-05 | PHASE4 |
| NCT04941196 | COMPLETED | Healthy Individuals |
University of Karachi |
2020-10-16 | PHASE1 |
| NCT04023630 | UNKNOWN | Atrial Fibrillation; Acute Coronary Syndromes |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2019-10-01 | PHASE4 |
| NCT03884530 | COMPLETED | Acute Stroke; Ischemic Stroke |
Kafrelsheikh University |
2019-05-01 | PHASE3 |
| NCT03822377 | COMPLETED | ST Elevation Myocardial Infarction; NSTEMI - Non-ST Segment Elevation MI |
Azienda Ospedaliero Universitaria di Sassari |
2019-06-27 | PHASE3 |
| NCT02913469 | UNKNOWN | ST-segment Elevation Myocardial Infarction |
General Hospital of Chinese Armed Police Forces |
2014-12-12 | PHASE4 |
| NCT03615924 | TERMINATED | Sickle Cell Disease |
AstraZeneca |
2018-09-26 | PHASE3 |
| NCT02053909 | COMPLETED | Saphenous Vein Graft Disease |
Boca Raton Regional Hospital |
2014-09 | PHASE4 |
| NCT02352402 | UNKNOWN | Coronary Artery Disease; Stable Angina; Acute Coronary Syndrome |
J.M. ten Berg |
2015-03 | PHASE3 |
| NCT03989557 | COMPLETED | Unruptured Intracranial Aneurysm; Stents; Antiplatelet Drugs |
Beijing Neurosurgical Institute |
2019-07-01 | PHASE4 |
| NCT02675205 | COMPLETED | Cerebral Aneurysm |
Fondation Ophtalmologique Adolphe de Rothschild |
2015-12 | PHASE3 |
| NCT02285751 | UNKNOWN | Critical Illness |
Medical University of Vienna |
2012-11 | PHASE2 |
| NCT02617290 | COMPLETED | Coronary Artery Disease; Myocardial Ischemia; Myocardial Infarction; Stent Thrombosis; Cardiovascular Diseases |
Assistance Publique - Hôpitaux de Paris |
2017-01-09 | PHASE3 |
| NCT02230527 | TERMINATED | Peripheral Arterial Disease |
The Cleveland Clinic |
2014-10 | PHASE2; PHASE3 |
| NCT04206176 | COMPLETED | Platelet Dysfunction Due to Drugs |
The University of The West Indies |
2019-10-01 | PHASE1; PHASE2 |
| NCT02989558 | COMPLETED | Aortic Valve Stenosis |
University of Athens |
2016-12 | PHASE3 |
| NCT02944123 | COMPLETED | Acute Coronary Syndrome |
Dong-A University |
2016-09 | PHASE3 |
| NCT03039205 | COMPLETED | Platelet Aggregation; Adenosine; Coronary Artery Disease; Kidney Dysfunction; Antiplatelet Therapy |
University of Sao Paulo |
2017-11-07 | PHASE2 |
| NCT03381755 | UNKNOWN | Acute Coronary Syndrome |
First Affiliated Hospital of Harbin Medical University |
2018-01-01 | PHASE4 |
| NCT03354429 | COMPLETED | Acute Ischaemic Stroke; Transient Ischaemic Attack |
AstraZeneca |
2018-01-22 | PHASE3 |
| NCT02341729 | COMPLETED | Acute Coronary Syndrome |
University Hospital, Ghent |
2015-03 | PHASE4 |
| NCT04369534 | COMPLETED | Acute Coronary Syndrome; STEMI; NSTEMI - Non-ST Segment Elevation MI; PLATELET AGGREGATION; INDIVIDUALIZED THERAPY |
University of Zagreb |
2015-12-01 | PHASE4 |
| NCT02539160 | COMPLETED | Coronary Artery Disease; Diabetes Mellitus |
University of Florida |
2016-02 | PHASE4 |
| NCT03400267 | COMPLETED | STEMI; STEMI - ST Elevation Myocardial Infarction |
A.H. Tavenier |
2018-02-16 | PHASE4 |
| NCT03928353 | COMPLETED | Healthy |
SFJ Pharmaceuticals, Inc. |
2019-04-16 | PHASE2 |
| NCT04962451 | COMPLETED | Cerebrovascular Accident; Cerebrovascular Accident, Acute |
Peking University Third Hospital |
2017-09-01 | PHASE4 |
| NCT03062462 | UNKNOWN | Coronary Artery Disease; Clopidogrel, Poor Metabolism of |
First Affiliated Hospital of Harbin Medical University |
2017-02-10 | PHASE2; PHASE3 |
| NCT02270242 | COMPLETED | Cardiovascular Disease; Interventional Cardiology |
Icahn School of Medicine at Mount Sinai |
2015-07 | PHASE4 |
| NCT01944800 | COMPLETED | Acute Coronary Syndrome (ACS) |
Deutsches Herzzentrum Muenchen |
2013-09-15 | PHASE4 |
| NCT03437044 | COMPLETED | Diabetes Mellitus, Type 2; Coronary Artery Disease |
University of Florida |
2018-03-14 | PHASE4 |
| NCT02866175 | COMPLETED | Atrial Fibrillation |
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company |
2017-02-24 | PHASE3 |
| NCT03182855 | UNKNOWN | Acute Coronary Syndrome; Myocardial Infarction; STEMI - ST Elevation Myocardial Infarction |
University of Aarhus |
2018-09-01 | PHASE4 |
| NCT02335099 | COMPLETED | End Stage Renal Disease; Vascular Access Patency |
University of Virginia |
2014-12 | PHASE1; PHASE2 |
| NCT02211066 | COMPLETED | Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion) |
Hospital Clinic of Barcelona |
2014-10 | PHASE4 |
| NCT03430661 | COMPLETED | Healthy |
Viatris Innovation GmbH |
2018-01-24 | PHASE1 |
| NCT03492931 | COMPLETED | Sickle Cell Disease |
AstraZeneca |
2018-03-28 | PHASE1 |
| NCT03614832 | UNKNOWN | Platelet Reactivity |
First Affiliated Hospital of Harbin Medical University |
2018-05-01 | PHASE4 |
| NCT02545933 | COMPLETED | Myocardial Infarction |
University of Florida |
2016-02 | PHASE4 |
| NCT03150667 | UNKNOWN | Chronic Kidney Diseases; Acute Coronary Syndrome |
North Texas Veterans Healthcare System |
2017-04-10 | PHASE4 |
| NCT02065479 | COMPLETED | Coronary Artery Disease |
University of Florida |
2014-03 | PHASE4 |
| NCT02874092 | COMPLETED | Rheumatoid Arthritis |
NYU Langone Health |
2016-11-15 | PHASE4 |
| NCT05643586 | COMPLETED | Coronary Artery Disease |
Germano Di Sciascio |
2017-12-01 | PHASE4 |
| NCT02762864 | UNKNOWN | Peripheral Artery Disease |
Chang Gung Memorial Hospital |
2016-05 | |
| NCT03489863 | COMPLETED | Coronary Artery Disease |
University of Florida |
2018-05-30 | PHASE4 |
| NCT03679091 | COMPLETED | Platelet Reactivity |
First Affiliated Hospital of Harbin Medical University |
2018-08-29 | PHASE4 |
| NCT02206815 | COMPLETED | Atrial Fibrillation; Coronary Artery Disease |
Genshan Ma |
2014-09-19 | PHASE4 |
| NCT02429271 | COMPLETED | Myocardial Infarction; ST Segment Elevation Myocardial Infarction (STEMI) |
Hellenic Cardiovascular Research Society |
2015-08 | PHASE3 |
| NCT03387826 | COMPLETED | Myocardial Infarction; Diabetes Mellitus; Coronary Artery Disease; Renal Disease |
Attikon Hospital |
2018-01-11 | PHASE4 |
| NCT01991795 | COMPLETED | Diabetes Mellitus, Type 2 |
AstraZeneca |
2014-02-10 | PHASE3 |
| NCT02486367 | COMPLETED | Aortic Stenosis; Inflammation; Thrombosis |
University Hospitals Cleveland Medical Center |
2015-06 | PHASE4 |
| NCT02931045 | COMPLETED | Myocardial Infarction |
Medical University of Warsaw |
2017-12-30 | PHASE4 |
| NCT03881943 | COMPLETED | Acute Coronary Syndrome |
The University of Hong Kong |
2017-01 | PHASE4 |
| NCT03247738 | COMPLETED | ST Segment Elevation Myocardial Infarction; Percutaneous Coronary Intervention |
University of Florida |
2017-11-20 | PHASE4 |
| NCT03381742 | COMPLETED | Coronary Artery Disease |
First Affiliated Hospital of Harbin Medical University |
2017-12-13 | PHASE2; PHASE3 |
| NCT02939248 | COMPLETED | Unstable Angina Pectoris |
Collegium Medicum w Bydgoszczy |
2016-10 | PHASE4 |
| NCT02748330 | COMPLETED | Coronary Artery Disease; Diabetes Mellitus, Type 2 |
Peking Union Medical College Hospital |
2016-06 | PHASE4 |
| NCT03145194 | UNKNOWN | ST Elevation Myocardial Infarction |
Papworth Hospital NHS Foundation Trust |
2017-01-30 | PHASE2 |
| NCT02094963 | COMPLETED | Acute Coronary Syndrome; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Angina Pectoris |
Seung-Jung Park |
2014-07-05 | PHASE4 |
| NCT02317198 | COMPLETED | Non-ST-elevation Acute Coronary Syndrome; Unstable Angina; Non-ST-elevation Myocardial Infarction |
St. Antonius Hospital |
2013-06 | PHASE4 |
| NCT03435133 | COMPLETED | ST Elevation Myocardial Infarction |
AORTICA Group |
2015-11-23 | |
| NCT02733341 | COMPLETED | Acute Coronary Syndrome (ACS); High On-treatment Platelet Reactivity (HTPR); Microvascular Obstruction (MVO); ST-segment Elevation Myocardial Infarction (STEMI); Thrombolysis in Myocardial Infarction (TIMI); Unstable Angina (UA) |
The Royal Wolverhampton Hospitals NHS Trust |
2016-07-21 | PHASE4 |
| NCT02627950 | COMPLETED | Acute Myocardial Infarction |
University of Luebeck |
2015-12 | PHASE4 |
| NCT03224923 | TERMINATED | Stable Coronary Syndrome; Percutaneous Coronary Intervention; Antiplatelet Therapy; Ticagrelor |
Ottawa Heart Institute Research Corporation |
2017-08-18 | PHASE4 |
| NCT03492385 | COMPLETED | Healthy |
SFJ Pharmaceuticals, Inc. |
2018-04-03 | PHASE1 |
| NCT02767401 | COMPLETED | Hibernation, Myocardial; Complete Occlusion of Coronary Artery |
The First Affiliated Hospital of Dalian Medical University |
2015-09-15 | PHASE4 |
| NCT02071212 | COMPLETED | Coronary Artery Disease |
Hellenic Cardiovascular Research Society |
2014-02 | PHASE2 |
| NCT02327624 | COMPLETED | Coronary Artery Disease |
Sheffield Teaching Hospitals NHS Foundation Trust |
2015-06 | PHASE4 |
| NCT02817789 | TERMINATED | Aortic Valve Stenosis |
University Hospital, Bordeaux |
2016-05-09 | PHASE3 |
| NCT02505399 | COMPLETED | Atherosclerosis |
University Hospital, Toulouse |
2015-11 | PHASE4 |
| NCT01755520 | TERMINATED | Coronary Artery Disease; Stable Angina; Acute Coronary Syndrome |
Deutsches Herzzentrum Muenchen |
2013-04-24 | PHASE3 |
| NCT02325466 | COMPLETED | Peripheral Artery Disease; Type 2 Diabetes |
Icahn School of Medicine at Mount Sinai |
2015-04 | PHASE3 |
| NCT02428725 | COMPLETED | Acute Coronary Syndrome |
Assistance Publique Hopitaux De Marseille |
2015-04 | |
| NCT02428374 | UNKNOWN | Myocardial Fibrosis |
Federal University of São Paulo |
2015-05 | PHASE4 |
| NCT03441412 | COMPLETED | Healthy Volunteers |
Vastra Gotaland Region |
2018-02-28 | PHASE1 |
| NCT03251859 | COMPLETED | Myocardial Infarction |
Collegium Medicum w Bydgoszczy |
2017-08-11 | PHASE3 |
| NCT02531165 | COMPLETED | Acute Myocardial Infarction |
Centre Hospitalier Universitaire Vaudois |
2015-09 | |
| NCT03104062 | COMPLETED | Coronary Microvascular Disease; Ticagrelor; Thrombolysis; Microbubble Contrasted Echocardiography |
University of Sao Paulo General Hospital |
2016-10-01 | |
| NCT02925923 | COMPLETED | Acute Coronary Syndrome; Angina, Unstable |
University of Alabama at Birmingham |
2016-11-01 | PHASE2 |
| NCT03577652 | COMPLETED | Coronary Artery Disease; Ticagrelor |
Shenyang Northern Hospital |
2017-07-10 | |
| NCT02792712 | UNKNOWN | Acute Coronary Syndrome |
Taipei Veterans General Hospital, Taiwan |
2016-01 | PHASE4 |
| NCT01739556 | TERMINATED | Acute ST-elevation Myocardial Infarction |
Clinical Centre of Serbia |
2015-06 | PHASE3 |
| NCT02626169 | WITHDRAWN | Atherosclerosis |
Baylor College of Medicine |
2015-12 | PHASE4 |
| NCT04174261 | COMPLETED | Periprocedural Myocardial Infarction |
Hellenic Society of Interventional Cardiology |
2017-01-29 | PHASE4 |
| NCT03119012 | TERMINATED | Coronary Artery Disease; Stents; Atherosclerosis |
Samsung Medical Center |
2017-04-19 | PHASE4 |
| NCT02298088 | COMPLETED | Acute ST Segment Elevation Myocardial Infarction; Thrombolysis in Myocardial Infarction Flow |
Hospital do Coracao |
2015-08 | PHASE3 |
| NCT03005704 | UNKNOWN | Ticagrelor; Aspirin; Platelet Dysfunction Due to Drugs; Transfusion |
Hamilton Health Sciences Corporation |
2017-01 | |
| NCT01743937 | TERMINATED | Ischemic Preconditioning |
University of Texas Southwestern Medical Center |
2013-01 | PHASE4 |
| NCT02942550 | COMPLETED | STEMI; Morphine; Ticagrelor; Methylnaltrexone |
Karolinska University Hospital |
2016-11 | PHASE4 |
| NCT02939235 | COMPLETED | Unstable Angina Pectoris |
Collegium Medicum w Bydgoszczy |
2016-07 | PHASE4 |
| NCT03016611 | UNKNOWN | Acute Coronary Syndrome; STEMI |
Sheba Medical Center |
2017-02 | PHASE4 |
| NCT02639143 | COMPLETED | Inflammation; Thrombosis |
First Affiliated Hospital of Harbin Medical University |
2015-12 | PHASE4 |
| NCT02943369 | COMPLETED | STEMI |
Attikon Hospital |
2017-07-28 | PHASE4 |
| NCT01701453 | UNKNOWN | Acute Coronary Syndrome |
Samsung Medical Center |
2012-08 | |
| NCT03487406 | COMPLETED | Chronic Obstructive Pulmonary Disease (COPD) |
Newcastle-upon-Tyne Hospitals NHS Trust |
2015-09 | PHASE2 |
| NCT03027934 | WITHDRAWN | Diabetes Mellitus |
CirQuest Labs, LLC |
2017-08-28 | PHASE4 |
| NCT02889549 | UNKNOWN | Coronary Artery Disease |
First Affiliated Hospital of Harbin Medical University |
2016-08 | PHASE2; PHASE3 |
| NCT02287909 | COMPLETED | Coronary Artery Disease |
University of Florida |
2014-12 | PHASE4 |
| NCT02518464 | COMPLETED | Migraine; Headache; Migraine Headache |
Columbia University |
2015-10 | PHASE4 |
| NCT02422888 | UNKNOWN | Myocardial Infarction |
Amsterdam UMC, location VUmc |
2015-05 | PHASE4 |
| NCT02627521 | UNKNOWN | Coronary Artery Disease |
Unity Health Toronto |
2015-07 | PHASE4 |
| NCT02507323 | WITHDRAWN | Cardiovascular Disease |
Yochai Birnbaum |
2016-02 | PHASE2 |
| NCT03126695 | COMPLETED | Sickle Cell Disease |
AstraZeneca |
2017-05-12 | PHASE1 |
| NCT02164864 | COMPLETED | Atrial Fibrillation; Percutaneous Coronary Intervention |
Boehringer Ingelheim |
2014-07-22 | PHASE3 |
| NCT02224534 | UNKNOWN | ST Elevation Myocardial Infarction |
Gyeongsang National University Hospital |
2014-10 | PHASE4 |
| NCT02663713 | COMPLETED | Myocardial Infarction; Diabetes Mellitus; Renal Disease; Coronary Artery Disease |
University of Patras |
2017-01 | PHASE4 |
| NCT02110303 | COMPLETED | Coronary Artery Disease |
University of Edinburgh |
2015-03 | PHASE2; PHASE3 |
| NCT02683707 | COMPLETED | Coronary Artery Disease |
Johns Hopkins University |
2016-03 | PHASE4 |
| NCT02224066 | COMPLETED | Severe Aortic Valve Stenosis; Transcatheter Aortic Valve Implantation; Transcatheter Aortic Valve Replacement |
Hospital de Meixoeiro |
2016-01 | PHASE4 |
| NCT02140801 | COMPLETED | Thrombosis |
Nanjing First Hospital, Nanjing Medical University |
2014-05-01 | PHASE4 |
| NCT02506140 | COMPLETED | Stroke; Ischemic Attack, Transient |
Beijing Tiantan Hospital |
2015-08 | PHASE2; PHASE3 |
| NCT02698618 | UNKNOWN | Diabetes Mellitus, Type 2 |
Fundacion Investigacion Interhospitalaria Cardiovascular |
2016-03 | PHASE4 |
| NCT02513004 | UNKNOWN | Coronary Disease |
Yongjian Wu |
2015-06 | PHASE4 |
| NCT02214121 | COMPLETED | Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease |
AstraZeneca |
2014-09-11 | PHASE2 |
| NCT02319941 | COMPLETED | Acute Coronary Syndrome |
Seung-Jung Park |
2015-05-20 | PHASE2 |
| NCT02587260 | COMPLETED | Cardiovascular Diseases |
Erasmus Medical Center |
2015-12-17 | PHASE4 |
| NCT02406248 | COMPLETED | Non ST-elevation Myocardial Infarction |
AstraZeneca |
2015-04-23 | PHASE4 |
| NCT02910778 | COMPLETED | Ischemia |
Medical University of Vienna |
2016-10 | PHASE4 |
| NCT02407314 | TERMINATED | Peripheral Arterial Disease |
Arkansas Heart Hospital |
2015-06 | PHASE4 |
| NCT02201771 | COMPLETED | Coronary Artery Bypass; Antiplatelet Agents |
Ruijin Hospital |
2014-07 | PHASE4 |
| NCT02725099 | COMPLETED | Acute Coronary Syndromes; ST Elevation Myocardial Infarction |
Sheba Medical Center |
2016-05 | PHASE4 |
| NCT01690884 | COMPLETED | Coronary Artery Disease |
Vanderbilt University |
2012-08 | PHASE1 |
| NCT01955200 | COMPLETED | Coronary Artery Disease |
The First Affiliated Hospital with Nanjing Medical University |
2013-10-05 | PHASE4 |
| NCT05278637 | COMPLETED | Platelet Aggregation Inhibitors; Aspirin; Ticagrelor; RNA |
Duke University |
2013-11-01 | EARLY_PHASE1 |
| NCT02457130 | UNKNOWN | Coronary Artery Disease; Diabetes Mellitus. Type 2 |
Spanish Society of Cardiology |
2015-04 | PHASE4 |
| NCT01738100 | UNKNOWN | ST-Segment Elevation Myocardial Infarction |
Hyeon-Cheol Gwon |
2012-09 | PHASE2 |
| NCT02415803 | UNKNOWN | Non ST Segment Elevation Acute Coronary Syndrome |
First Affiliated Hospital of Harbin Medical University |
2014-12 | PHASE3 |
| NCT02798874 | UNKNOWN | Cardiovascular Diseases |
Chinese PLA General Hospital |
2016-05 | |
| NCT02618733 | COMPLETED | Acute Coronary Syndrome |
Dong-A University |
2014-12 | |
| NCT02379676 | UNKNOWN | Endothelial Dysfunction; Vascular Inflammation |
Kiyuk Chang |
2015-01 | PHASE4 |
| NCT02091921 | COMPLETED | Critical Limb Ischemia |
University of Southern California |
2014-02-16 | PHASE1; PHASE2 |
| NCT02482298 | COMPLETED | Sickle Cell Disease |
AstraZeneca |
2015-07-09 | PHASE2 |
| NCT02284048 | UNKNOWN | Microvascular Angina |
Second Xiangya Hospital of Central South University |
2014-11 | PHASE4 |
| NCT02383771 | COMPLETED | Coronary Artery Disease |
The First Affiliated Hospital with Nanjing Medical University |
2015-03 | PHASE4 |
| NCT02376283 | COMPLETED | Heart Attack |
The Royal Wolverhampton Hospitals NHS Trust |
2015-03-09 | PHASE4 |
| NCT02293395 | COMPLETED | Acute Coronary Syndrome |
Janssen Research & Development, LLC |
2015-04-20 | PHASE2 |
| NCT02330640 | COMPLETED | Antiplatelet Therapy of Coronary Artery Bypass |
Chinese Academy of Medical Sciences, Fuwai Hospital |
2016-01 | PHASE4 |
| NCT02044146 | COMPLETED | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
Ottawa Heart Institute Research Corporation |
2014-09 | PHASE2; PHASE3 |
| NCT01930591 | COMPLETED | Acute Myocardial Infarction |
Unity Health Toronto |
2014-05 | PHASE3 |
| NCT02037412 | TERMINATED | Acute Coronary Syndrome; Acute Myocardial Infarction; Unstable Angina (Intermediate Coronary Syndrome) |
Yonsei University |
2014-01 | PHASE4 |
| NCT01732822 | COMPLETED | Peripheral Artery Disease |
AstraZeneca |
2012-12-04 | PHASE3 |
| NCT02233790 | UNKNOWN | Myocardial Infarction; No-Reflow Phenomenon |
First Hospital of China Medical University |
2014-12 | PHASE4 |
| NCT02244710 | COMPLETED | Acute Coronary Syndrome (ACS) |
Fundación Investigación Sanitaria en León |
2015-03 | |
| NCT02612116 | COMPLETED | Unstable Angina Pectoris |
Collegium Medicum w Bydgoszczy |
2015-09 | PHASE4 |
| NCT02658838 | UNKNOWN | LOVASTATIN/TICAGRELOR [VA Drug Interaction] |
Beijing Anzhen Hospital |
2015-04 | PHASE4 |
| NCT02201667 | UNKNOWN | Acute Coronary Syndrome |
RenJi Hospital |
2014-08 | PHASE4 |
| NCT02487732 | COMPLETED | Acute Coronary Syndrome |
Korea University Anam Hospital |
2015-07 | PHASE4 |
| NCT01830543 | COMPLETED | Atrial Fibrillation; Percutaneous Coronary Intervention |
Janssen Scientific Affairs, LLC |
2013-05-10 | PHASE3 |
| NCT02070653 | COMPLETED | Abdominal Aortic Aneurysm |
Uppsala University |
2014-03 | PHASE2 |
| NCT02169596 | COMPLETED | Acute Coronary Syndome |
Hull University Teaching Hospitals NHS Trust |
2015-06 | PHASE4 |
| NCT01700322 | COMPLETED | Coronary Artery Disease |
Johannes Gutenberg University Mainz |
2012-08 | PHASE4 |
| NCT02201394 | COMPLETED | Coronary Artery Disease |
Icahn School of Medicine at Mount Sinai |
2014-07 | PHASE4 |
| NCT02224274 | COMPLETED | Cardiac Arrest; Postresuscitation Syndrome; Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction) |
University Medical Centre Ljubljana |
2014-08 | PHASE4 |
| NCT02519608 | COMPLETED | Coronary Artery Disease; Chronic Obstructive Pulmonary Disease |
University Hospital of Ferrara |
2015-09 | PHASE2 |
| NCT02291419 | TERMINATED | Myocardial Injury |
The Cleveland Clinic |
2015-07 | PHASE4 |
| NCT01883869 | COMPLETED | Pneumonia; Community Acquired Pneumonia; Hospital Acquired Pneumonia; Acute Lung Injury |
University of Kentucky |
2013-06 | PHASE1 |
| NCT02227368 | TERMINATED | Peripheral Artery Disease (PAD) |
AstraZeneca |
2014-10-20 | PHASE2 |
| NCT01823510 | COMPLETED | Type-2 Diabetes Mellitus; Coronary Artery Disease |
Juan J Badimon |
2013-07 | PHASE4 |
| NCT02022748 | COMPLETED | Kidney Failure, Chronic |
AstraZeneca |
2013-12-29 | PHASE1 |
| NCT02123004 | UNKNOWN | ST-Segment Elevation Myocardial Infarction |
Jinan Central Hospital |
2014-04 | PHASE4 |
| NCT02808767 | COMPLETED | Myocardial Infarction; Angioplasty, Balloon, Coronary; Platelet Aggregation Inhibitors |
Faculty Hospital Kralovske Vinohrady |
2013-01 | PHASE4 |
| NCT02403830 | COMPLETED | Coronary Artery Disease |
University of Florida |
2015-08 | PHASE4 |
| NCT02282332 | COMPLETED | Coronary Artery Disease |
Medstar Health Research Institute |
2014-06 | PHASE4 |
| NCT02578537 | UNKNOWN | Non ST Segment Elevation Acute Coronary Syndrome; Chronic Kidney Disease |
Shenyang Northern Hospital |
2015-10 | PHASE4 |
| NCT02041650 | COMPLETED | Acute Coronary Syndrome |
Yu Bo |
2014-08 | PHASE4 |
| NCT01994720 | COMPLETED | Acute Ischaemic Stroke; Transient Ischaemic Attack |
AstraZeneca |
2014-01-07 | PHASE3 |
| NCT02048228 | UNKNOWN | CLOPIDOGREL, POOR METABOLISM of (Disorder) |
Chinese PLA General Hospital |
2014-10 | PHASE2; PHASE3 |
| NCT02580149 | COMPLETED | Ischemia |
Michael Wolzt, Prof. MD |
2015-10 | PHASE4 |
| NCT02402400 | COMPLETED | Acute Coronary Syndromes; Non ST Elevation Myocardial Infarction |
Sheba Medical Center |
2015-07 | PHASE4 |
| NCT01805596 | COMPLETED | Coronary Artery Disease; Endothelial Function |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2013-04 | PHASE3 |
| NCT02121288 | WITHDRAWN | Peripheral Artery Disease; Vascular Disease; Arterial Occlusion Disease; Intermittent Claudication; Ankle Brachial Index (0.9 or Less) |
AstraZeneca |
2014-12 | PHASE4 |
| NCT02469740 | COMPLETED | Myocardial Ischemia; Coronary Artery Disease; Endothelial Dysfunction |
University Hospital of Limerick |
2015-07 | PHASE4 |
| NCT01823185 | UNKNOWN | Coronary Artery Disease; Myocardial Infarction; Heart Disease; Vascular Disease; Angina Pectoris; Cardiovascular Disease; Ischemia; Infarction; Embolism; Thrombosis; Chest Pain |
Imam Abdulrahman Bin Faisal University |
2013-03 | PHASE4 |
| NCT01957540 | COMPLETED | Coronary Artery Disease; Endothelial Function |
University of Patras |
2014-06 | PHASE4 |
| NCT02612480 | COMPLETED | Endotoxemia |
Radboud University Medical Center |
2015-10 | |
| NCT02071966 | TERMINATED | Non ST Segment Elevation Acute Coronary Syndrome |
Catholic University of the Sacred Heart |
2012-11 | PHASE4 |
| NCT01812330 | UNKNOWN | Acute Coronary Syndrome |
General Hospital of Chinese Armed Police Forces |
2013-01 | PHASE3 |
| NCT02459288 | UNKNOWN | Acute Coronary Syndrome; Chronic Kidney Disease; End-Stage Renal Disease |
Ping-Yen Liu |
2014-01 | PHASE4 |
| NCT01998399 | TERMINATED | Community Acquired Pneumonia, Severe |
Gordon Bernard |
2014-08 | PHASE2 |
| NCT01962428 | COMPLETED | Non ST Segment Elevation Acute Coronary Syndrome |
General Hospital of Chinese Armed Police Forces |
2014-06 | PHASE4 |
| NCT01919723 | COMPLETED | Acute Coronary Syndrome |
University of Alabama at Birmingham |
2014-02 | PHASE2 |
| NCT02311088 | TERMINATED | Dyspnea |
Uppsala University |
2014-12 | PHASE2 |
| NCT01869309 | UNKNOWN | Coronary Artery Disease |
LifeBridge Health |
2014-01 | PHASE4 |
| NCT01813435 | COMPLETED | Coronary Artery Disease (CAD) |
ECRI bv |
2013-07-01 | PHASE3 |
| NCT03092076 | COMPLETED | Healthy |
Guangdong Provincial People's Hospital |
2015-05-20 | PHASE1 |
| NCT02081443 | COMPLETED | Coronary Artery Disease |
University of Florida |
2014-04 | |
| NCT02261922 | UNKNOWN | Antiplatelet Agents; Endothelial Function; Pleotropic Effects |
Hotel Dieu de France Hospital |
2014-10 | PHASE4 |
| NCT02514642 | UNKNOWN | Coronary Artery Disease |
First Affiliated Hospital of Harbin Medical University |
2015-07 | PHASE4 |
| NCT02016170 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome |
University of Florida |
2014-03 | |
| NCT01870921 | COMPLETED | Acute Coronary Syndrome |
AstraZeneca |
2013-06-26 | PHASE4 |
| NCT02699008 | COMPLETED | Acute Coronary Syndrome |
Wuhan Asia Heart Hospital |
2014-01 | |
| NCT02394145 | UNKNOWN | Chronic Kidney Disease |
Kyunghee University Medical Center |
2009-09 | PHASE3 |
| NCT01994941 | COMPLETED | Acute Coronary Syndrome |
The University of Hong Kong |
2013-08 | PHASE4 |
| NCT02436577 | COMPLETED | Bioequivalence; Healthy Japanese Subjects; Pharmacokinetics |
AstraZeneca |
2015-06 | PHASE1 |
| NCT01905566 | COMPLETED | Plaque, Atherosclerotic |
CHEOL WHAN LEE, M.D., Ph.D |
2013-09 | PHASE4 |
| NCT02400333 | COMPLETED | Bioavailability; Healthy Subjects |
AstraZeneca |
2015-06 | PHASE1 |
| NCT01852214 | COMPLETED | Diabetes Mellitus; Coronary Artery Disease |
University of Florida |
2013-02 | |
| NCT01531114 | COMPLETED | ST-Elevation Myocardial Infarction |
Gennaro Sardella |
2013-05 | PHASE3 |
| NCT02217878 | COMPLETED | ST-segment Elevation Myocardial Infarction; Non-ST-segment Elevation Myocardial Infarction; VA Drug Interactions |
Collegium Medicum w Bydgoszczy |
2014-08 | PHASE4 |
| NCT02406911 | UNKNOWN | Chronic Kidney Disease |
Kyunghee University Medical Center |
2015-02 | PHASE3 |
| NCT02742987 | COMPLETED | Coronary Artery Disease; Diabetes Mellitus |
Campus Bio-Medico University |
2014-03 | PHASE4 |
| NCT02219412 | COMPLETED | Coronary Heart Disease |
Yong Huo |
2014-08 | PHASE4 |
| NCT02048085 | WITHDRAWN | Acute ST Segment Elevation Myocardial Infarction; Acute Coronary Syndrome |
Medical Center of South Arkansas |
2014-01-02 | PHASE4 |
| NCT02052635 | TERMINATED | Non-ST Elevation Acute Coronary Syndrome |
AstraZeneca |
2014-09 | PHASE4 |
| NCT02075125 | TERMINATED | ST-Segment Elevation Myocardial Infarction |
Dong-A University |
2014-01 | PHASE3 |
| NCT02435563 | COMPLETED | Healthy |
University Hospital, Geneva |
2014-08 | PHASE2 |
| NCT01373411 | COMPLETED | Coronary Artery Disease |
Cardiology Research UBC |
2011-09 | PHASE4 |
| NCT01894789 | COMPLETED | Coronary Artery Disease |
Ottawa Heart Institute Research Corporation |
2013-03 | PHASE2; PHASE3 |
| NCT02054663 | COMPLETED | Acute Coronary Syndrome |
Ottawa Heart Institute Research Corporation |
2013-12 | PHASE4 |
| NCT01916902 | WITHDRAWN | Acute Coronary Syndrome; Coronary Artery Disease |
Massachusetts General Hospital |
2014-02 | PHASE4 |
| NCT02046486 | COMPLETED | ST Elevation Myocardial Infarction |
University of Patras |
2014-01 | PHASE4 |
| NCT02012140 | UNKNOWN | Cardiovascular Disease; Stable Angina; Myocardial Infarction; Coronary Artery Disease |
LifeBridge Health |
2014-01 | PHASE4 |
| NCT02032290 | UNKNOWN | Acute Coronary Syndrome:; Non ST Elevation Myocardial Infarction; ST Elevation Myocardial Infarction; Unstable Angina |
Azienda Policlinico Umberto I |
2014-02 | PHASE4 |
| NCT01225562 | COMPLETED | Myocardial Infarction; Cardiovascular Death; Atherothrombosis; Stroke |
AstraZeneca |
2010-10 | PHASE3 |
| NCT01950416 | COMPLETED | ST Elevation Myocardial Infarction; Fibrinolysis; P2Y12 Inhibitor |
University of Patras |
2013-03 | PHASE4 |
| NCT02032303 | UNKNOWN | Acute Coronary Syndrome; Non ST Elevation Myocardial Infarction; ST Elevation Myocardial Infarction; Unstable Angina |
Azienda Policlinico Umberto I |
2014-02 | PHASE4 |
| NCT02064985 | COMPLETED | Stable Coronary Heart Disease (CHD) |
AstraZeneca |
2014-02 | PHASE4 |
| NCT02080858 | COMPLETED | Atrial Fibrillation; Acute Coronary Syndrome |
Medical University of Vienna |
2014-05 | PHASE1 |
| NCT02026219 | COMPLETED | Non-ST Segment Elevation Myocardial Infarction; ST Segment Elevation Myocardial Infarction |
Inha University Hospital |
2013-10 | PHASE4 |
| NCT02108808 | COMPLETED | Fractional Flow Reserve |
University of Patras |
2014-04 | PHASE4 |
| NCT02215993 | COMPLETED | Acute Coronary Syndrome; Platelet Function |
Federal University of São Paulo |
2013-07 | PHASE4 |
| NCT01643031 | UNKNOWN | Diabetes Mellitus; Coronary Disease |
Rabin Medical Center |
2012-08 | PHASE4 |
| NCT01852175 | COMPLETED | Coronary Artery Disease |
University of Florida |
2012-01 | |
| NCT01898442 | COMPLETED | Coronary Artery Disease |
University of Florida |
2013-09 | PHASE2 |
| NCT01603082 | COMPLETED | Acute Coronary Syndrome |
AstraZeneca |
2012-07 | PHASE4 |
| NCT02101437 | COMPLETED | PRU; miRNA |
Taipei City Hospital |
2014-01 | |
| NCT01731041 | COMPLETED | Coronary Artery Disease |
University of Florida |
2013-01 | |
| NCT01826175 | WITHDRAWN | Acute Coronary Syndrome; Coronary Artery Disease |
Massachusetts General Hospital |
2013-05 | PHASE4 |
| NCT01744288 | COMPLETED | Inhibition on Platelet Aggregation |
AstraZeneca |
2012-12 | PHASE1 |
| NCT02086903 | COMPLETED | Pharmacodynamics |
Dong-A University |
2014-02 | PHASE3 |
| NCT01456364 | UNKNOWN | Coronary Heart Disease |
Deutsches Herzzentrum Muenchen |
2011-09 | PHASE4 |
| NCT01706510 | COMPLETED | Coronary Artery Disease |
Rapid City Regional Hospital, Inc |
2012-12 | PHASE4 |
| NCT01864005 | COMPLETED | Non-ST or ST Elevation Acute Coronary Syndromes |
AstraZeneca |
2013-05 | PHASE4 |
| NCT01992523 | COMPLETED | Acute Coronary Syndrome; Adverse Reaction to Antiplatelet Agent |
David Antoniucci |
2013-11 | PHASE3 |
| NCT01961856 | COMPLETED | Platelet Reactivity |
University of Patras |
2013-09 | PHASE3 |
| NCT01626534 | COMPLETED | Acute Coronary Syndrome |
Assistance Publique Hopitaux De Marseille |
2012-03 | PHASE3 |
| NCT01846559 | COMPLETED | Healthy |
Sheffield Teaching Hospitals NHS Foundation Trust |
2013-04 | PHASE4 |
| NCT02120092 | COMPLETED | Acute Coronary Syndrome |
Medical University of Vienna |
2010-10 | PHASE2 |
| NCT01543932 | COMPLETED | Coronary Artery Disease |
University of Roma La Sapienza |
2012-07 | PHASE3 |
| NCT01996735 | COMPLETED | Healthy |
Radboud University Medical Center |
2013-04 | PHASE4 |
| NCT01347580 | COMPLETED | Myocardial Infarction; Segment Elevation Myocardial Infarction (STEMI) |
AstraZeneca |
2011-09 | PHASE4 |
| NCT01523392 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2012-03 | PHASE4 |
| NCT01887626 | COMPLETED | Bioavailability Heathy Volunteers |
AstraZeneca |
2013-07 | PHASE1 |
| NCT02163954 | COMPLETED | Chronic Kidney Disease |
Kyunghee University Medical Center |
2013-01 | PHASE3 |
| NCT01660373 | UNKNOWN | Non-ST Segment Elevation Acute Coronary Syndrome |
Pusan National University Yangsan Hospital |
2012-08 | PHASE3 |
| NCT01876797 | COMPLETED | Healthy |
Asan Medical Center |
2013-07 | PHASE1 |
| NCT01734772 | COMPLETED | Healthy |
Boehringer Ingelheim |
2012-11 | PHASE1 |
| NCT01523366 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2012-04 | PHASE4 |
| NCT01812200 | COMPLETED | Atrial Fibrillation; Acute Coronary Syndrome |
Medical University of Vienna |
2012-10 | PHASE4 |
| NCT01757262 | WITHDRAWN | Coronary Heart Disease |
AstraZeneca |
2013-01 | PHASE3 |
| NCT01805570 | COMPLETED | Myocardial Infarction |
David Antoniucci |
2012-11 | PHASE4 |
| NCT01642238 | COMPLETED | Acute Coronary Syndrome |
Juan J Badimon |
2012-07 | PHASE4 |
| NCT01587651 | COMPLETED | Coronary Artery Disease |
Daiichi Sankyo |
2012-03 | PHASE4 |
| NCT01766466 | COMPLETED | Coronary Artery Disease |
The Medicines Company |
2013-01 | PHASE2 |
| NCT01575795 | COMPLETED | ST-elevation Myocardial Infarction |
University of Patras |
2012-04 | PHASE4 |
| NCT01795820 | COMPLETED | Acute Coronary Syndrome |
University Magna Graecia |
2012-11 | |
| NCT01515345 | COMPLETED | Platelet Inhibition; Coronary Stent Implantation |
Kaiser Franz Josef Hospital |
2011-07 | PHASE3 |
| NCT01526577 | COMPLETED | Acute Coronary Syndrome |
LG Life Sciences |
2012-03 | PHASE1 |
| NCT01642966 | COMPLETED | Acute Coronary Syndrome |
University of Patras |
2012-09 | PHASE4 |
| NCT01642940 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome |
University of Patras |
2012-06 | PHASE4 |
| NCT01294462 | COMPLETED | Acute Coronary Syndrome; Percutaneous Coronary Intervention |
AstraZeneca |
2011-02 | PHASE3 |
| NCT01504906 | COMPLETED | Healthy |
AstraZeneca |
2012-01 | PHASE1 |
| NCT01510171 | COMPLETED | ST-segment Elevation Myocardial Infarction |
Careggi Hospital |
2012-01 | PHASE4 |
| NCT01595854 | COMPLETED | Healthy |
Boehringer Ingelheim |
2012-05 | PHASE1 |
| NCT01463163 | COMPLETED | Platelet Reactivity |
University of Patras |
2011-10 | PHASE4 |
| NCT01350921 | COMPLETED | Drug Drug Interaction |
AstraZeneca |
2011-05 | PHASE1 |
| NCT01511471 | COMPLETED | Platelet Reactivity |
University of Patras |
2012-01 | PHASE3 |
| NCT01360437 | COMPLETED | Coronary Artery Disease; Acute Coronary Syndrome |
University of Patras |
2011-05 | PHASE3 |
| NCT01226602 | COMPLETED | Blood Flow Speed; Coronary Flow Velocity |
AstraZeneca |
2010-12 | PHASE1 |
| NCT01118325 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2010-04 | PHASE2 |
| NCT00528411 | COMPLETED | Coronary Artery Disease |
AstraZeneca |
2007-10 | PHASE2 |
| NCT00391872 | COMPLETED | Acute Coronary Syndrome |
AstraZeneca |
2006-10 | PHASE3 |
| NCT00642811 | COMPLETED | Stable Coronary Artery Disease |
AstraZeneca |
2008-05 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2026-03-10)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).